Found 629 matching trials
Effects of SGLT2 Inhibitors on Erythropoiesis in Heart Failure
N/AThis retrospective cohort study investigates the effects of SGLT2 inhibitor...
Status
Active Not Recruiting
Location
University Medical Centre Ljubljana
Comparison of Empaglifozin and Vildagliptin in Type 2 Diabetes Mellitus
PHASE4The aim of this study is to perform a comparison of the efficacy and safety...
Location
Department of Diabetes and Endocrinology at Sindh Government Hospital New Karachi & Dr. Riasat Medical Center Allah Wala Town, Karachi, Pakistan
Bioequivalence Study to Compare Empagliflozin + Linagliptin 25 mg/5 mg Film-coated Tablets Versus Glyxambi 25 mg/ 5 mg Film-coated Tablets
PHASE1An open label, balanced, randomized, single dose, two treatment, two sequen...
Location
Veeda Clinical Research Ltd.
Sodium-glucose Transport 2 Inhibitors (SGLT2i) in HFrEF Patients
NAThe aim of this study is to assess the efficacy, safety and cardiovascular ...
Location
Damanhour Teaching Hospital, General Organization for Teaching Hospitals and Institutes.
Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
PHASE2Sickle cell anemia (SCA) is an inherited red blood disorder. The kidneys ar...
Location
University of Illinois Chicago, Sickle Cell Center
Effect of Sodium Glucose Co-transporter 2 Inhibitor on Inflammatory Cytokine in Type 2 Diabetes
NA* Single-center, prospective, active-controlled, open, randomized, 2 arm pa...
Location
Yonsei University College of Medicine, Department of Internal Medicine, Division of Endocrinology, Severance Hospital, Diabetes center
Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors
PHASE4Inhibition of dipeptidyl peptidase-4 (DPP-4) or sodium-glucose co-transport...
Location
Kurume University Hospital
Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH
PHASE2A randomized, multi-center study evaluating MET409 (50 mg) alone or in comb...
Location
Metacrine Investigative Site
Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)
PHASE3Comparison of 2 doses of empagliflozin vs placebo in patients already using...
Location
AMCR Institute, Inc.
Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)
PHASE4BEYOND represents an open-label, parallel, three-arm randomized controlled ...
Location
Unit of Endocrinology and Metabolic Diseases